Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 27 ... uses a short gene sequence from a standardised region of the genome as a diagnostic 'biomarker' for species.""This study aimed to quantify genetic data currently ...
2009 NOV 24 ... sequencing, but we also have established a first-mover advantage in diagnostics and biomarker discovery using single molecule sequencing technology. Our recent strategic dialogues ...
2009 NOV 24 ... the increased percentage of CD27(-) or CD28(-) HCMV-specific subsets can be considered a biomarker of HCMV replication in solid organ transplant recipients younger than age 50 years but ...
2009 NOV 27 ... report."The subjects were participating in a five-day inpatient clinical biomarker study during which time they were allowed to smoke their own brand of cigarette whenever ...
2009 NOV 23 ... the National Academy of Sciences of the United States of America (IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas. Proceedings of the ...
2009 NOV 23 ... highly sensitive electronic chip would offer an ideal platform for clinical biomarker readout and would have maximal utility if it was (i) multiplexed, enabling on-chip ...
2009 NOV 23 ... using stable isotope labeling strategies combined with MS is an important tool for biomarker discovery. involving stable isotope metabolic labeling result in optimal quantitative ...
2009 NOV 23 ... Technical University of Munich. The researchers concluded: "Whether the biomarker profile is chemotherapy-specific or whether it is a more general indicator of bad ...
2009 NOV 24 ... M2a- or M2cM phi. CCL17 and CXCL13 (biomarkers for M2a- and M2cM phi), but not CCL1 (a biomarker of M2bM phi), were produced by MLM phi from thermally injured CCL2(-/-) mice treated ...
2009 NOV 23 ... neuropsychiatric diagnostics services. RBM recently announced the identification of a biomarker panel demonstrating clinical utility for the differential diagnosis of schizophrenia. ...
2009 NOV 23 ... can serve as a valuable reference for the study of embryo implantation and for future biomarker discovery involved in pathologic alterations of endometrial function." ...
2009 NOV 23 ... findings indicate that IFN-induced gene expression has limited clinical utility as a biomarker of acute changes in disease activity." Landoltmarticorena and colleagues ...
2009 NOV 23 ... peaks for subsequent validation and illustrates the need for appropriate controls in biomarker studies to determine whether changes are indirect consequences of treatment." ...
2009 NOV 23 ... increasing pressure has been placed on more effective clinical approaches and biomarker assays to manage care. For bladder cancer despite the high probability of recurrence the ...
2009 NOV 23 ... and proteomic profiles of pleural effusion from lung adenocarcinoma patients for NSCLC biomarker discovery," scientists in Taiwan report. "Retinoblastoma-associated ...
2009 NOV 28 ... (TARC)/CCL17 have been observed in atopic dermatitis (AD) and may serve as a new biomarker for AD. However, the normal levels, especially in children, have not been well ...
2009 NOV 23 ... of ethnicity in north-Indian population may represent an important susceptibility biomarker for cervical cancer risk as well as other diseases and should be explored further." ...
2009 NOV 23 ... to the Company for the discovery of biomarkers for ovarian cancer. The patent covers biomarker combinations for both the diagnosis and management of ovarian cancer and covers ...
2009 NOV 23 ... and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and ...
